Total Payments
$4,968
2024 Payments
$272.72
Companies
33
Transactions
255
Medicare Patients
3,126
Medicare Billing
$425,529
Payment Breakdown by Category
Food & Beverage$3,238 (65.2%)
Other$1,640 (33.0%)
Education$89.93 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,238 | 246 | 65.2% |
| Honoraria | $1,640 | 2 | 33.0% |
| Education | $89.93 | 7 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,077 | 93 | $0 (2024) |
| HILL-ROM SERVICES, INC | $840.00 | 1 | $0 (2019) |
| Hill-Rom Holdings, Inc | $800.00 | 1 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $454.53 | 58 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $278.95 | 19 | $0 (2023) |
| GENZYME CORPORATION | $273.31 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $235.16 | 11 | $0 (2023) |
| Genentech USA, Inc. | $137.48 | 8 | $0 (2023) |
| Amgen Inc. | $83.74 | 4 | $0 (2024) |
| Mylan Specialty L.P. | $77.45 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $272.72 | 10 | GlaxoSmithKline, LLC. ($190.63) |
| 2023 | $709.75 | 39 | GlaxoSmithKline, LLC. ($198.97) |
| 2022 | $276.39 | 11 | GENZYME CORPORATION ($113.10) |
| 2021 | $46.21 | 4 | Sunovion Pharmaceuticals Inc. ($31.82) |
| 2020 | $966.21 | 12 | Hill-Rom Holdings, Inc ($800.00) |
| 2019 | $1,345 | 45 | HILL-ROM SERVICES, INC ($840.00) |
| 2018 | $532.35 | 54 | GlaxoSmithKline, LLC. ($175.84) |
| 2017 | $819.50 | 80 | GlaxoSmithKline, LLC. ($265.26) |
All Payment Transactions
255 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $122.27 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Pulmonology | ||||||
| 02/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 01/23/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Inflammation | ||||||
| 01/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Immunology | ||||||
| 12/04/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology | ||||||
| 11/09/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/03/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $9.00 | General |
| 10/24/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Inflammation | ||||||
| 10/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Immunology | ||||||
| 10/16/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $18.25 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 10/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Immunology | ||||||
| 08/10/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 663 | 997 | $151,917 | $80,237 |
| 2022 | 15 | 830 | 1,205 | $167,523 | $83,113 |
| 2021 | 12 | 802 | 1,430 | $315,817 | $137,141 |
| 2020 | 11 | 831 | 1,284 | $320,843 | $125,038 |
Total Patients
3,126
Total Services
4,916
Medicare Billing
$425,529
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 45 | 127 | $42,291 | $21,041 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 174 | $27,840 | $16,411 | 58.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 220 | $23,540 | $13,710 | 58.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 109 | $16,895 | $10,221 | 60.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 57 | $17,157 | $7,516 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $11,568 | $5,833 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 24 | $2,640 | $1,339 | 50.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 27 | 27 | $2,268 | $991.57 | 43.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 26 | 26 | $2,002 | $978.69 | 48.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 24 | 24 | $2,016 | $611.73 | 30.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 41 | 41 | $738.00 | $345.58 | 46.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 16 | 16 | $784.00 | $338.91 | 43.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 41 | 41 | $820.00 | $296.37 | 36.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 40 | 40 | $520.00 | $249.84 | 48.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 11 | 11 | $550.00 | $201.72 | 36.7% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 12 | 12 | $288.00 | $151.69 | 52.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 114 | 308 | $32,956 | $17,146 | 52.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 44 | 104 | $34,632 | $16,239 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 149 | $23,840 | $14,450 | 60.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 117 | $18,135 | $9,394 | 51.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 59 | $17,759 | $8,673 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $9,158 | $4,980 | 54.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 75 | 76 | $6,384 | $2,396 | 37.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 71 | 72 | $5,544 | $2,291 | 41.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $3,075 | $1,596 | 51.9% |
About Dr. Christopher Schmitt, M.D
Dr. Christopher Schmitt, M.D is a Pulmonary Disease healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548210370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Schmitt, M.D has received a total of $4,968 in payments from pharmaceutical and medical device companies, with $272.72 received in 2024. These payments were reported across 255 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,238).
As a Medicare-enrolled provider, Schmitt has provided services to 3,126 Medicare beneficiaries, totaling 4,916 services with total Medicare billing of $425,529. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Cincinnati, OH
- Active Since 05/11/2006
- Last Updated 08/10/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1548210370
Products in Payments
- Progressa Bed System (Device) $840.00
- None (Device) $800.00
- NUCALA (Biological) $458.44
- DUPIXENT (Biological) $380.42
- TRELEGY ELLIPTA (Drug) $240.43
- LONHALA MAGNAIR (Drug) $204.62
- ANORO (Drug) $172.21
- OFEV (Drug) $151.34
- BREO (Drug) $123.12
- BREZTRI (Drug) $110.89
- Xolair (Biological) $103.55
- Utibron (Drug) $92.03
- STIOLTO (Drug) $87.75
- TEZSPIRE (Biological) $83.74
- BROVANA (Drug) $61.76
- SYMBICORT (Drug) $59.21
- The Vest System Model 105 Home Care (Device) $56.19
- GLASSIA (Biological) $54.77
- Dymista (Drug) $54.19
- UTIBRON (Drug) $48.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cincinnati
Shahrokh Javaheri, Md, MD
Pulmonary Disease — Payments: $431,707
Pulmonary Disease $431,707
Christopher Radchenko, M.d, M.D
Pulmonary Disease — Payments: $13,708
Pulmonary Disease $13,708
Dr. Karthikeyan Kanagarajan, M.d, M.D
Pulmonary Disease — Payments: $5,575
Pulmonary Disease $5,575
Dr. Shahla Mallick, Md, MD
Pulmonary Disease — Payments: $4,853
Pulmonary Disease $4,853
Daniel Murphy, Md, MD
Pulmonary Disease — Payments: $3,835
Pulmonary Disease $3,835
Krishna Gannamraj, D.o, D.O
Pulmonary Disease — Payments: $3,039
Pulmonary Disease $3,039